Меню
Идёт набор NCT07219680

Intervention for Communication Quality of Life in Primary Progressive Aphasia

Без фазы С лечением Primary Progressive Aphasia(PPA) Semantic Dementia Logopenic Progressive Aphasia (LPA) Nonfluent Aphasia, Progressive

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Multicomponent Lexical Retrieval Cascade Training, Multicomponent Video Implemented Script Training in Aphasia.
Кому может быть актуально
Состояния в реестре: Primary Progressive Aphasia(PPA), Semantic Dementia, Logopenic Progressive Aphasia (LPA), Nonfluent Aphasia, Progressive. Базовые параметры: от 40 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Intervention to Promote Communication Quality of Life for Persons With Language-Led Dementia and Their Partners: A Randomized Pilot Trial

Обзор

The goal of this clinical trial is to learn whether a personalized, multi-component, virtual speech language treatment program can improve communication and quality of life for adults with primary progressive aphasia (PPA) and their primary communication partners. The study will enroll participants who speak English and/or Spanish. The main questions the study aims to answer are: * Is the telerehabilitation program feasible and acceptable for people with PPA and their study partners? * Do participants with PPA and study partners find treatment beneficial? * What patterns of treatment response are seen in participants? * Which outcome measures are most useful for evaluating changes in communication and quality of life? Researchers will compare participants who receive intervention immediately to participants assigned to a waitlist control group (who will receive treatment after a delay) to see whether participation in the treatment program is associated with improvements in communication and quality of life. Participants will: * Take part in speech language therapy sessions delivered by video visit that combine restorative, compensatory, and partner-focused communication strategies. Treatment may take place after a waiting period. * Receive education and communication training together with their partner. * Complete speech, language, and cognitive assessments. * Complete questionnaires about communication abilities, daily functioning, and quality of life.

Вмешательства

  • Поведенческое Multicomponent Lexical Retrieval Cascade Training
    In person or via teletherapy: A multi-component treatment incorporating elements of restitutive, compensatory, and care-partner focused interventions. Participants work on producing names of personally relevant targets in multiple communication modalities. Biweekly (45-90 minute) sessions with a clinician target multimodal communication and the use of strategies to support word retrieval. These skills are also trained via daily independent practice. The participant meets six times during the cou
  • Поведенческое Multicomponent Video Implemented Script Training in Aphasia
    In person or via teletherapy: A multi-component treatment incorporating elements of restitutive, compensatory, and care-partner focused interventions. Treatment focuses on production of individually-tailored, personally relevant scripts. The participant completes 30 minutes per day of independent practice, during which they speak in unison with a video model. Biweekly (45-90 minute) sessions with a clinician target clear and accurate script production, memorization, and conversational usage, as

Первичные конечные точки

  • Change in spoken naming of trained/untrained items [Срок оценки: change from pre-treatment or waitlist to post-treatment or waitlist (12-13 weeks), and follow-up at 3 months post-treatment]
  • Change in script production accuracy [Срок оценки: change from pre-treatment or waitlist to post-treatment or waitlist (12-13 weeks), and follow-up at 3 months post-treatment]
  • Change in barriers and facilitators in dyad conversation [Срок оценки: change from pre-treatment or waitlist to post-treatment or waitlist (12-13 weeks), and follow-up at 3 months post-treatment]
  • Communication Modality Inventory [Срок оценки: change from pre-treatment or waitlist to post-treatment or waitlist (12-13 weeks), and follow-up at 3 months post-treatment]
Вторичные конечные точки (5)
  • Change on Quick Aphasia Battery [Срок оценки: change from pre-treatment or waitlist to post-treatment or waitlist (12-13 weeks), and follow-up at 3 months post-treatment]
  • Change on Aphasia Impact Questionnaire [Срок оценки: change from pre-treatment or waitlist to post-treatment or waitlist (12-13 weeks), and follow-up at 3 months post-treatment]
  • Acceptability and Perception of Change Survey [Срок оценки: post-treatment (approximately 12-13 weeks after treatment onset)]
  • Change on Adult Carers Quality of Life Questionnaire [Срок оценки: change from pre-treatment or waitlist to post-treatment or waitlist (12-13 weeks), and follow-up at 3 months post-treatment]
  • Change on Brief - Coping Orientation to Problems Experienced Inventory (Brief-COPE) [Срок оценки: change from pre-treatment or waitlist to post-treatment or waitlist (12-13 weeks), and follow-up at 3 months post-treatment]

Критерии участия

Inclusion Criteria for Persons with PPA:

  • A PPA (Gorno-Tempini et al., 2011) or "PPA-plus" (Mesulam et al., 2001) diagnosis
  • MMSE score of 15 or higher and must be able to produce single monosyllabic words intelligibly
  • Must speak English, Spanish or both languages (i.e., bilingual speakers of English or Spanish)
  • Hearing and vision adequate for participation in teleconference meetings
  • Must have a study partner available (someone who will commit to attending teleconference sessions, as needed, during assessment and treatment phases)

Inclusion criteria for Care Partners:

  • Partners must express willingness to attend and participate in assessment and treatment sessions, including those targeting dyadic communication goals
  • Partners must speak English, Spanish or both languages (i.e., bilingual speakers of English or Spanish)
  • Partner's hearing and vision should be adequate for participation in teleconference meetings

The participant and/or study partner must have basic experience using a computer.

Exclusion criteria for persons with PPA:

  • Other central nervous system or medical diagnosis that can account for symptoms
  • Psychiatric diagnosis that can account for symptoms

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Лечение

Центры проведения

США · 1 центр
  • University of Texas — Austin

Публикации

  • Henry ML, Hubbard HI, Grasso SM, Mandelli ML, Wilson SM, Sathishkumar MT, Fridriksson J, Daigle W, Boxer AL, Miller BL, Gorno-Tempini ML. Retraining speech production and fluency in non-fluent/agrammatic primary progressive aphasia. Brain. 2018 Jun 1;141(6):1799-1814. doi: 10.1093/brain/awy101. PMID 29718131
  • Henry ML, Hubbard HI, Grasso SM, Dial HR, Beeson PM, Miller BL, Gorno-Tempini ML. Treatment for Word Retrieval in Semantic and Logopenic Variants of Primary Progressive Aphasia: Immediate and Long-Term Outcomes. J Speech Lang Hear Res. 2019 Aug 15;62(8):2723-2749. doi: 10.1044/2018_JSLHR-L-18-0144. Epub 2019 Aug 7. PMID 31390290
  • Dial HR, Hinshelwood HA, Grasso SM, Hubbard HI, Gorno-Tempini ML, Henry ML. Investigating the utility of teletherapy in individuals with primary progressive aphasia. Clin Interv Aging. 2019 Feb 25;14:453-471. doi: 10.2147/CIA.S178878. eCollection 2019. PMID 30880927

Идентификаторы

NCT: NCT07219680 · R61AG089318

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗